TCT-574 Comparison of everolimus-eluting stents with first (paclitaxel, sirolimus) and second-generation (zotarolimus, biolimus) drug-eluting stents in patients with acute coronary syndromes [Katowice-Zabrze Registry on first and second generation DES

Damian Kawecki,Wojciech M Wanha,Beata Morawiec,Janusz Dola,Aleksandra Pluta,Kamil Marcinkiewicz,Tomasz Roleder,Grzegorz A Smolka,Andrzej J Ochala,Michal Tendera,Wojciech Wojakowski

doi:10.1016/j.jacc.2014.07.637

TCT-574 Comparison of everolimus-eluting stents with first (paclitaxel, sirolimus) and second-generation (zotarolimus, biolimus) drug-eluting stents in patients with acute coronary syndromes [Katowice-Zabrze Registry on first and second generation DES

Damian Kawecki, Wojciech M Wanha + Show 9 more

Open Access

https://doi.org/10.1016/j.jacc.2014.07.637

Copy DOI

Journal: Journal of the American College of Cardiology	Publication Date: Sep 1, 2014
License type: publisher-specific-oa

Affiliation: Medical University of Silesia

#Drug Eluting Stents #Safety Of Everolimus-eluting Stents + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

The aim of this study was to compare the efficacy and safety of everolimus-eluting stents (EES) in treatment of patient with coronary artery disease (CAD) as compared to other drug eluting stents (DES): paclitaxel eluting stents (PES), sirolimus eluting stents (SES), zotarolimus eluting stents (ZES

Full Text